Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial

Martina Capponi1, Denise Pires Marafon1, Flaminia Rivosecchi2

  • 1Division of Rheumatology, Ospedale Pediatrico Bambino Gesù, IRCCS (ERN-RITA center), Rome, Italy.

Abstract

Insights

The Radiological Activity Index (RAI-CROMRIS) quantifies bone involvement in nonbacterial osteomyelitis, correlating with clinical and lab markers. This MRI-based tool shows promise for clinical practice and trials.

Area of Science:

  • Radiology
  • Medical Imaging
  • Osteomyelitis Research

Background:

  • Nonbacterial osteomyelitis presents diagnostic challenges.
  • The ChRonic nonbacterial Osteomyelitis MRI Scoring tool (CROMRIS) was recently developed.
  • A need existed for a quantitative measure of overall bone involvement.

Purpose of the Study:

  • To develop and validate the Radiological Activity Index (RAI-CROMRIS).
  • To quantify overall bone involvement in nonbacterial osteomyelitis using MRI.
  • To assess the correlation of RAI-CROMRIS with clinical and laboratory disease activity measures.

Main Methods:

  • Whole Body Magnetic Resonance Imaging (WB-MRI) was utilized.
  • RAI-CROMRIS parameters included bone marrow hyperintensity, signal extension, soft tissue/periosteal hyperintensity, bony expansion, and vertebral collapse.
  • 76 treatment-naïve patients were assessed, with 46 followed for 12 months. Statistical analysis included Mann-Whitney U and Wilcoxon signed-rank tests, and Spearman's rank correlation.

Main Results:

  • RAI-CROMRIS significantly correlated with physician global assessment (PGA) and inflammatory markers (ESR, CRP) at baseline.
  • RAI-CROMRIS scores decreased significantly from baseline to 6 and 12 months post-treatment.
  • Higher baseline RAI-CROMRIS was observed in patients treated with bisphosphonates, with significant reduction post-treatment.

Conclusions:

  • RAI-CROMRIS effectively correlates with clinical and laboratory measures of disease activity in nonbacterial osteomyelitis.
  • The tool demonstrated significant short-term changes following bisphosphonate treatment.
  • RAI-CROMRIS shows potential utility in clinical practice and trials for nonbacterial osteomyelitis management.